| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |